Feifei Su
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Cardiac electrophysiology and arrhythmias
Papers in ⓘ
-
- Cardiac electrophysiology and arrhythmias 5
- Cardiac Fibrosis and Remodeling 4
- Atrial Fibrillation Management and Outcomes 3
- Cardiac Arrhythmias and Treatments 2
- Cardiomyopathy and Myosin Studies 2
-
- Signaling Pathways in Disease 3
- Co-authors
- Chenchan Hu (2 shared papers)Jianping Huang (2 shared papers)Jianyi Dai (2 shared papers)Qifa Song (1 shared paper)Xiaokun Li (1 shared paper)Xiaoming Zhang (1 shared paper)Chen Dong (1 shared paper)Boyuan Fan (3 shared papers)
- Journals
- Scientific Reports (3 papers)PLoS ONE (2 papers)Frontiers in Microbiology (2 papers)International Journal of Medical Sciences (1 paper)Journal of Molecular and Cellular Cardiology (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Feifei Su
33 papers receiving 722 citations
Peers
Comparison fields: 5 of 112
- Infectious Diseases 206
- Cardiology and Cardiovascular Medicine 169
- Neurology 89
- Cancer Research 72
- Molecular Biology 264
Countries citing papers authored by Feifei Su
This map shows the geographic impact of Feifei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Su more than expected).
Fields of papers citing papers by Feifei Su
This network shows the impact of papers produced by Feifei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Su. The network helps show where Feifei Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 197 | |
| 2 | 2018 | 64 | |
| 3 | 2016 | 52 | |
| 4 | 2014 | 46 | |
| 5 | 2016 | 37 | |
| 6 | 2015 | 34 | |
| 7 | 2020 | 28 | |
| 8 | 2012 | 27 | |
| 9 | 2018 | 26 | |
| 10 | 2019 | 25 | |
| 11 | 2015 | 22 | |
| 12 | 2020 | 22 | |
| 13 | 2018 | 19 | |
| 14 | 2022 | 19 | |
| 15 | 2012 | 13 | |
| 16 | 2013 | 13 | |
| 17 | 2022 | 11 | |
| 18 | 2023 | 10 | |
| 19 | 2016 | 10 | |
| 20 | 2009 | 8 |
About Feifei Su
Feifei Su is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Infectious Diseases, Surgery and Epidemiology, having authored 36 papers that have together received 738 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (5 papers), Cardiac Fibrosis and Remodeling (4 papers), Signaling Pathways in Disease (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Cardiac Arrhythmias and Treatments (2 papers) and Cardiomyopathy and Myosin Studies (2 papers). The work is most often cited by research in Infectious Diseases (206 citations), Cardiology and Cardiovascular Medicine (169 citations), Neurology (89 citations), Cancer Research (72 citations) and Molecular Biology (264 citations). Feifei Su has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Chenchan Hu, Jianping Huang, Jianyi Dai, Qifa Song, Xiaokun Li, Xiaoming Zhang, Chen Dong, Boyuan Fan, Hong Tan and Jie Qi. Their work appears in journals such as Scientific Reports, PLoS ONE, Frontiers in Microbiology, International Journal of Medical Sciences and Journal of Molecular and Cellular Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.